Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Estrogen and the Urogenital Microbiome in GSM
NCT03336437Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Feb 2018
- Primary completion
- Aug 2019
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of estradiol in genitourinary syndrome of menopause (GSM), sponsored by Oregon Health & Science University. Started Feb 2018; status: completed.
02
Drugs
estradiol
03
Conditions
genitourinary syndrome of menopause (GSM)
Beyond the preview
Go deeper on NCT03336437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03336437.